Voyager Therapeutics
voyagertherapeutics.com
Health Care
Neurology & CNS Therapeutics
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Visa sponsorship
- United States · H-1B filings in 12 months: 5 · green card filings: 2
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Foresite CapitalVia a fund
Wellington ManagementVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Report
Voyager to Present at Upcoming Investor Conferences
LEXINGTON, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that the company will participate in the following upc
Read more
Report
Report
Report
Report
Report
Report
Show more news
People
Robert Hesslein
Executive Officer
Todd Carter
Executive Officer
Robin Swartz
Executive Officer
Alfred Sandrock
Executive Officer, Director
Peter Pfreundschuh
Executive Officer
Jacquelyn Fahey Sandell
Executive Officer
Steven Hyman
Director
James Geraghty
Director
Grace Colon
Director
Jude Onyia
Director
Glenn Pierce
Director
Nancy Vitale
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Cambridge
United States
HQ
Lexington
United States
Regional office
Disciplined Execution.
Voyager Therapeutics, Inc. • 75 Hayden Avenue, Lexington, MA 02421 • 857.259.5340